Drynachromoside ACAS# 1507388-29-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 1507388-29-5 | SDF | Download SDF |
| PubChem ID | 71661133 | Appearance | Powder |
| Formula | C22H28O13 | M.Wt | 500.45 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 7-[(2S,3R,4S,5R,6S)-3,4-dihydroxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-methylchromen-4-one | ||
| SMILES | CC1C(C(C(C(O1)OC2=CC(=C3C(=C2)OC(=CC3=O)C)O)O)O)OC4C(C(C(C(O4)CO)O)O)O | ||
| Standard InChIKey | BEVXGYXIMDDDHJ-HHLLRHCNSA-N | ||
| Standard InChI | InChI=1S/C22H28O13/c1-7-3-10(24)14-11(25)4-9(5-12(14)31-7)33-21-19(30)17(28)20(8(2)32-21)35-22-18(29)16(27)15(26)13(6-23)34-22/h3-5,8,13,15-23,25-30H,6H2,1-2H3/t8-,13+,15+,16-,17-,18+,19+,20-,21-,22-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Drynachromoside A exhibits the biochemical effects on the proliferation of MC3T3-E1 cells. |
Drynachromoside A Dilution Calculator
Drynachromoside A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.9982 mL | 9.991 mL | 19.982 mL | 39.964 mL | 49.955 mL |
| 5 mM | 0.3996 mL | 1.9982 mL | 3.9964 mL | 7.9928 mL | 9.991 mL |
| 10 mM | 0.1998 mL | 0.9991 mL | 1.9982 mL | 3.9964 mL | 4.9955 mL |
| 50 mM | 0.04 mL | 0.1998 mL | 0.3996 mL | 0.7993 mL | 0.9991 mL |
| 100 mM | 0.02 mL | 0.0999 mL | 0.1998 mL | 0.3996 mL | 0.4996 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Calyxamine B
Catalog No.:BCN1671
CAS No.:150710-72-8
- 5-Methoxycanthin-6-one
Catalog No.:BCN3326
CAS No.:15071-56-4
- Tolvaptan
Catalog No.:BCC5096
CAS No.:150683-30-0
- Fmoc-Lys(Dde)-OH
Catalog No.:BCC3518
CAS No.:150629-67-7
- epi-Eudesmol
Catalog No.:BCN1670
CAS No.:15051-81-7
- L-NIL hydrochloride
Catalog No.:BCC5706
CAS No.:150403-89-7
- o-Methoxycinnamaldehyde
Catalog No.:BCN3860
CAS No.:1504-74-1
- Pemetrexed disodium
Catalog No.:BCN2179
CAS No.:150399-23-8
- MRS 2690
Catalog No.:BCC7514
CAS No.:15039-58-4
- SR 49059
Catalog No.:BCC7324
CAS No.:150375-75-0
- Sivelestat sodium salt
Catalog No.:BCC2368
CAS No.:150374-95-1
- threo-7-O-Methylguaiacylglycerol beta-coniferyl ether
Catalog No.:BCN6929
CAS No.:150333-85-0
- Gap19
Catalog No.:BCC5599
CAS No.:1507930-57-5
- Oxybutynin chloride
Catalog No.:BCC4149
CAS No.:1508-65-2
- Tropicamide
Catalog No.:BCC4574
CAS No.:1508-75-4
- Retigabine
Catalog No.:BCC6427
CAS No.:150812-12-7
- Retigabine dihydrochloride
Catalog No.:BCC1890
CAS No.:150812-13-8
- 2,3,24-Trihydroxyolean-12-en-28-oic acid
Catalog No.:BCN1559
CAS No.:150821-16-2
- Nitenpyram
Catalog No.:BCC5559
CAS No.:150824-47-8
- EGF816
Catalog No.:BCC6428
CAS No.:1508250-71-2
- Boc-Orn(Fmoc)-OH
Catalog No.:BCC3429
CAS No.:150828-96-9
- Micromelin
Catalog No.:BCN1672
CAS No.:15085-71-9
- Uralenol-3-methylether
Catalog No.:BCN7993
CAS No.:150853-98-8
- Bis(phenylacetyl) disulfide
Catalog No.:BCC8887
CAS No.:15088-78-5
Two new chromone glycosides from Drynaria fortunei.[Pubmed:23160089]
Fitoterapia. 2013 Jan;84:130-4.
Two new chromone glycosides, Drynachromoside A (1), drynachromoside B (2), along with three known flavanones, 5,7,3',5'-tetrahydroxy-flavanone (3), 5,7,3',5'-tetrahydroxy-flavanone-7-O-beta-d-glucopyranoside (4), and 5,7,3',5'-tetrahydroxy-flavanone-7-O-neohesperidoside (5), were isolated from the dry rhizomes of Drynaria fortunei by means of bio-active screening. The two former compounds were elucidated on the basis of physico-chemical property and spectroscopic data. The osteoblastic proliferation activities of these flavonoids were evaluated by the method of MTT. The results showed that compound 1 exhibited the biochemical effects on the proliferation of MC3T3-E1 cells, while Compound 2 showed inhibitory effects against MC3T3-E1 cells.
Five new chromone glycosides from Scindapsus officinalis (Roxb.) Schott.[Pubmed:28882671]
Fitoterapia. 2017 Oct;122:101-106.
Five new chromone glycosides, officinalisides A (1), B (2), C (3), D (4) and E (5) were isolated from Scindapsus officinalis (Roxb.) Schott., along with six known chromone derivatives, 7-O-alpha-l-rhamnosyl-nereugenin (6), undulatoside A (7), Drynachromoside A (8), drynachromoside B (9), 5,7-dihydroxy-2-methyl chromone(10), 5,7-dihydroxy-2-hydroxymethyl chromone (11). Structural elucidation of the isolated compounds was established by spectroscopic analysis, especially 2D NMR techniques and comparison with literatures. The isolates were evaluated for anti-inflammatory activities in a LPS-stimulated RAW 264.7 model using inhibition of nitric oxide (NO) production as an indicator. Compounds 2, 4 and 10 demonstrated potential anti-inflammatory activity with IC50 values of 16.1, 19.1, and 13.4muM, respectively, compared to the positive control dexamethasone.
